Company Overview
Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company, focused on the development of drugs to treat gastrointestinal disorders and diseases, rheumatoid arthritis, neuroendocrine cancer, and acute leukemia. The companyÂ’'s lead drug candidates include SP-304, a guanylyl cyclase C (GC-C) receptor agonist for the treatment of chronic constipation and constipation-predominant irritable bowel syndrome, which is in Phase 2a clinical trial; and SP-333, a GC-C receptor agonist that is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. Its drug candidates also comprise Atiprimod, an orally administered drug with antiproliferative, ant...
read more


To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 420 Lexington Avenue, Suite 1609, New York, NY 10170, United States
Mailing Address: -
Phone: 212-297-0010
Fax: 212-297-0020
Website: http//

Company Details:

Symbol: CLSP
SIC: -
State location: NY
Sector: -
State of Inc: DE
Employees: 6
Type: -

Key executives:

Name Age Position
Bernard Denoyer 73 Prinicipal Financial Officer, Principal Accounting Officer and VP of Fin.
Gabriele M. Cerrone 48 Chairman and Consultant
Gary S. Jacob Ph.D. 74 Chief Exec. Officer, Chief Scientific Officer, Exec. Director and Chairman of Synergy Pharmaceuticals Inc
Moshe Talpaz M.D. 2021 Chairman of Scientific Advisory Board and Consultant